Welcome to our dedicated page for Astronics SEC filings (Ticker: ATROB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Astronics Corporation filings document material-event disclosures, operating-result announcements, and capital-structure transactions. The company’s 8-K reports include Item 2.02 releases covering preliminary adjusted EBITDA margin information and conference presentation materials. Other filings describe material definitive agreements tied to convertible senior notes, capped call transactions, repurchases of existing convertible notes, use of proceeds, and borrowings under an ABL revolving credit facility. These records also identify the company’s New York incorporation, Exchange Act reporting framework, and related exhibit filings.
Mulato James reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp reported that James Mulato, President of Astronics Test Systems, received a grant of 7,675 restricted stock units on February 19, 2026 at no cash cost. Each unit represents the right to receive one share of common stock at settlement.
The filing explains that vesting of these restricted stock units depends on Astronics Corp's average annual adjusted EBITDA over specified multi‑year periods. Between 50% and 150% of the applicable target unit amounts may vest on future February dates, with the actual vesting percentage determined by the company’s performance.
Capital International Investors has filed a Schedule 13G reporting a passive ownership stake in Astronics Corp. common stock. The firm is deemed to beneficially own 1,849,886 shares, representing 5.9% of Astronics’ 31,619,410 shares believed to be outstanding as of the reported date.
The filing states Capital International Investors has sole voting and dispositive power over all 1,849,886 shares and no shared power. It also certifies the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Astronics.
American Century Investment Management and related entities reported a significant ownership position in Astronics Corporation. They disclosed beneficial ownership of 1,764,235 shares of Astronics common stock, representing 5.6% of the outstanding class as of December 31, 2025.
American Century and its parent American Century Companies, Inc., together with the Stowers Institute for Medical Research, reported sole voting power over 1,453,455 shares and sole dispositive power over 1,764,235 shares, with no shared voting or dispositive power. They certified that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics.
PEABODY MARK reported disposition transactions in a Form 4 filing for ATRO. The filing lists transactions totaling 2,500 shares. Following the reported transactions, holdings were 183,445 shares.
State Street Corporation has disclosed a significant ownership position in Astronics Corp common stock. It reports beneficial ownership of 1,832,179 shares, representing 5.8% of Astronics’ common stock as of 12/31/2025.
State Street has shared voting power over 1,755,956 shares and shared dispositive power over 1,832,179 shares, with no sole voting or dispositive power. The firm states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics.
Astronics Corporation filed a current report to note that on February 5, 2026 it issued a news release announcing preliminary unaudited adjusted EBITDA margins for the fourth quarter and full year of 2025. The company also highlighted plans to webcast its presentations at the TD Cowen Aerospace & Defense Conference.
BlackRock, Inc. has filed an amended Schedule 13G showing a significant passive stake in Astronics Corp common stock. As of 12/31/2025, BlackRock reports beneficial ownership of 2,749,452 shares, representing 8.7% of the outstanding common stock. BlackRock has sole voting power over 2,701,240 shares and sole dispositive power over all 2,749,452 shares, with no shared voting or dispositive power.
The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics. Various underlying clients have rights to dividends or sale proceeds, but no single client has more than five percent of Astronics’ outstanding common shares.
Astronics Corporation issued senior unsecured notes that produced approximately $216.7 million of net proceeds. The company used about $26.9 million to pay for capped call transactions and, together with $85.0 million of borrowings under its ABL Revolving Credit Facility and $11.0 million of cash on hand, repurchased approximately $132.0 million principal amount of its 5.500% Convertible Senior Notes due 2030. The new Notes, issued under an indenture, mature on January 15, 2031, bear no regular interest and do not accrete. Conversion rights are limited prior to October 15, 2030, and on conversion the company may settle with cash and/or shares subject to the terms. The company entered into capped call transactions with option counterparties to reduce potential dilution, with an initial cap price near $83.4051 per share. The Indenture includes customary Events of Default, repurchase rights on Fundamental Change, and specified redemption windows.